Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $7.00 USD
Change Today -1.00 / -12.50%
Volume 1.7K
BRTX On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

biorestorative therapies inc (BRTX) Snapshot

Open
$7.43
Previous Close
$8.00
Day High
$7.99
Day Low
$7.00
52 Week High
07/9/15 - $12.25
52 Week Low
10/9/14 - $5.20
Market Cap
19.8M
Average Volume 10 Days
1.1K
EPS TTM
--
Shares Outstanding
2.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIORESTORATIVE THERAPIES INC (BRTX)

Related News

No related news articles were found.

biorestorative therapies inc (BRTX) Related Businessweek News

No Related Businessweek News Found

biorestorative therapies inc (BRTX) Details

BioRestorative Therapies, Inc., a development stage company, develops medical therapies using cell and tissue protocols, primarily involving adult stem cells that allow patients to undergo cellular-based treatments. The company’s products and medical therapies include brtxDISC, a cell therapy candidate that focuses on providing non-surgical treatment for protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease; and ThermoStem program, which focuses on the treatment of metabolic diseases, such as type 2 diabetes, obesity, hypertension, and other metabolic disorders, as well as cardiac deficiencies. It also provides Curved Needle Device, a needle system with a curved inner cannula to access difficult-to-locate regions for the delivery or removal of fluids and other substances. In addition, the company offers human and plant stem cell derived cosmetic and skin care products under the Stem Pearls brand; and develops a human adult stem cell-derived extract that enhances the production of collagen and fibronectin for combating the aging of skin. It has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; and Pfizer, Inc. to provide research and development services. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York.

7 Employees
Last Reported Date: 03/31/15
Founded in 1997

biorestorative therapies inc (BRTX) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $675.0K
Vice President of Operations and Secretary
Total Annual Compensation: $118.0K
Vice President of Research & Development
Total Annual Compensation: $255.0K
Compensation as of Fiscal Year 2014.

biorestorative therapies inc (BRTX) Key Developments

BioRestorative Therapies, Inc. will Change its Ticker to BRTX from BRTX.D

Effective August 03, 2015, BioRestorative Therapies, Inc. will change its Pink Sheets LLC stock ticker symbol to BRTX from BRTX.D.

BioRestorative Therapies, Inc. Amends its Certificate of Incorporation

On May 28, 2015, BioRestorative Therapies, Inc. held special meeting of stockholders. At this meeting, the company's shareholders approved amendments to the Certificate of Incorporation of the company, and authorization of the Board of Directors of the company to select and file one such amendment, to effect a reverse stock split of the company’s common stock at a ratio of not less than 1-for-5 and not more than 1-for-30, with the Board of Directors of the Company having the discretion as to whether or not the reverse stock split is to be effected, and with the exact ratio of any reverse stock split to be set at a whole number within the above range as determined by the company’s Board of Directors in its discretion.

BioRestorative Therapies, Inc. Presents at Marcum Microcap Conference 2015, May-28-2015 02:00 PM

BioRestorative Therapies, Inc. Presents at Marcum Microcap Conference 2015, May-28-2015 02:00 PM. Venue: Grand Hyatt New York, Park Avenue at Grand Central, New York, NY 10017, United States. Speakers: Mark R. Weinreb, Chairman, Chief Executive Officer and President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRTX:US $7.00 USD -1.00

BRTX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Athersys Inc $1.13 USD 0.00
Caladrius Biosciences Inc $1.74 USD +0.095
Cytori Therapeutics Inc $0.37 USD +0.0167
IntelliCell BioSciences Inc $0.0002 USD 0.00
StemCells Inc $0.52 USD +0.0512
View Industry Companies
 

Industry Analysis

BRTX

Industry Average

Valuation BRTX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 31.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 37.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIORESTORATIVE THERAPIES INC, please visit www.biorestorative.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.